| |
References
|
Cefditoren 200 mg bid
|
Cefditoren 400 mg bid
|
Comparatorsa
|
|---|
|
EOTb
|
EFc
|
EOTb
|
EFc
|
EOTb
|
EFc
|
|---|
|
Pharyngotonsillitis
|
90-92
|
93.4 – 98.6
|
88.9–99.2
|
–
|
–
|
88.6–97.1
|
84.4–100
|
|
Rhinosinusitis
|
90,93
|
81.3–95.2
|
63.6–91.0
|
76.5–83.1
|
70.2–71.9
|
75.5–97.7
|
66.2–95.1
|
|
AECBd
|
89,94–97
|
80–88.8
|
79.7–83.0
|
84.4–95.5
|
78.1–85.6
|
75.0–98.9
|
79.8–85.7
|
|
CAPe
|
89,98,99
|
87.2 – 91.8
|
88.4–87.8
|
89.2–90.1
|
83.7–87.2
|
90.3–92.2
|
87.8–93.8
|
- aPenicillin V or VK (90–92) for pharyngotonsillitis, amoxicillin/clavulanic acid (90,93) or cefuroxime (90) for rhinosinusitis, cefuroxime (89,94,96) or clarithromycin (89,95) for AECB, and amoxicillin/clavulanic acid (89,98), and cefpodoxime (89,99) for CAP
- bEOT = End of Treatment
- cEF = End of Follow up
- dAECB = Acute exacerbation of chronic bronchitis
- eCAP = Community-acquired pneumonia
